
    
      This study compares the efficacy and safety of intravenous (IV) iron (VIT45) versus oral iron
      (ferrous sulfate) administered to subjects who suffer from anemia and are diagnosed with
      non-dialysis dependent chronic kidney disease (NDD-CKD).
    
  